Semustine

Semustine

SCHEMBL15569770

CC1CCC(NC(=O)N(CCCl)N=O)CC1.O=P1(N(CCCl)CCCl)NCCCO1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 0.65
ALDH1A1 P00352 2/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
NPSR1 Q6W5P4 1/20 0.53
PDE4A P27815 1/20 0.53
ADRA1A P35348 1/20 0.53
KDM4E B2RXH2 1/20 0.52
ALOX15 P16050 1/20 0.52
MAPK1 P28482 1/20 0.52
MEN1 O00255 1/20 0.33
ABCB11 O95342 1/20 0.33
GSR P00390 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
KMT2A Q03164 1/20 0.33
EPHX1 P07099 1/20 0.32
CRYZ Q08257 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lomustine SCHEMBL168490 0.92 ADRA2A (0.64) ADRA2AALDH1A1SMN1; SMN2NPSR1PDE4A
Semustine SCHEMBL4500 0.80 ALDH1A1 (1.00) ADRA2AALDH1A1SMN1; SMN2PDE4AADRA1A
Semustine SCHEMBL4959160 0.80 ALDH1A1 (1.00) ADRA2AALDH1A1SMN1; SMN2PDE4AADRA1A
Cyclophosphamide Anhydrous SCHEMBL5364682 0.80 NPSR1 (0.61) ADRA2AALDH1A1SMN1; SMN2NPSR1PDE4A
Semustine SCHEMBL2350016 0.79 ALDH1A1 (0.92) ADRA2AALDH1A1SMN1; SMN2NPSR1PDE4A
Semustine SCHEMBL28854924 0.79 ALDH1A1 (0.97) ADRA2AALDH1A1SMN1; SMN2PDE4AADRA1A
Semustine SCHEMBL8980108 0.73 ALDH1A1 (0.79) ADRA2AALDH1A1SMN1; SMN2PDE4AADRA1A
Fotemustine SCHEMBL20505097 0.73 NPSR1 (0.48) ADRA2AALDH1A1SMN1; SMN2NPSR1PDE4A
Cyclophosphamide Anhydrous SCHEMBL14192809 0.73 NPSR1 (1.00) NPSR1KDM4EALOX15MAPK1CRYZ
Cyclophosphamide Anhydrous SCHEMBL1285823 0.73 NPSR1 (1.00) NPSR1KDM4EALOX15MAPK1CRYZ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3137447-A1 INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF Rgenix, Inc. (US) 2017-03-08 EP disclosed
WO-2016176636-A1 INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF RGENIX, INC. (US) 2016-11-03 WO disclosed
WO-2015168465-A1 INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF RGENIX, INC. (US) 2015-11-05 WO disclosed
EP-2882496-A2 TREATMENT AND DIAGNOSIS OF MELANOMA The Rockefeller University (US) 2015-06-17 EP disclosed
WO-2014028461-A2 TREATMENT AND DIAGNOSIS OF MELANOMA THE ROCKEFELLER UNIVERSITY (US) 2014-02-20 WO disclosed